# New Methods to Measure the Immune Response to Hepatitis B Vaccine

> **NCT01821547** · PHASE4 · COMPLETED · sponsor: **University of Oxford** · enrollment: 21 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Hepatitis B vaccine

## Key facts

- **NCT ID:** NCT01821547
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-04
- **Final completion:** 2016-05
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01821547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01821547, "New Methods to Measure the Immune Response to Hepatitis B Vaccine". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01821547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*